You are here

Article info

Article menu
Download PDFPDF
Review
Developing tolerogenic dendritic cell therapy for rheumatoid arthritis: what can we learn from mouse models?

Authors

  1. Correspondence to Dr Catharien M U Hilkens, Institute of Cellular Medicine,Musculoskeletal Research Group, Faculty of Medical Sciences, Newcastle University, Framlington Place, Newcastle upon Tyne NE2 4HH, UK; catharien.hilkens{at}newcastle.ac.uk
View Full Text

Citation

Stoop JN, Robinson JH, Hilkens CMU
Developing tolerogenic dendritic cell therapy for rheumatoid arthritis: what can we learn from mouse models?
Annals of the Rheumatic Diseases 2011;70:1526-1533.

Publication history

  • Accepted June 12, 2011
  • First published July 30, 2011.
Online issue publication 
April 09, 2023

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions